CellCarta Strengthens its Histological Biomarker Franchise by Acquiring Artificial Intelligence-Based Quantitative Pathology Leader Reveal Biosciences
CellCarta, a global provider of precision medicine services, announced today the acquisition of Reveal Biosciences ("Reveal"), a San Diego California based computational pathology company offering cutting-edge artificial intelligence (AI)-based quantitative pathology and immunohistochemistry services to the biopharmaceutical industry. This acquisition further strengthens CellCarta's position as a leading provider of histopathology biomarker services and will enable the company to broaden its offering in AI-enabled multi-omic data analysis services and applications.
Reveal Biosciences has created a new generation of Pathology Intelligence(TM) to enhance research, clinical trials, and improve patient outcomes globally. Reveal's imageDx(TM) pathology platform combines cutting edge machine learning (ML)-AI with traditional histopathology to transform tissue biology into actionable data. Reveal's unique proprietary pipeline architecture and biomarker-based training methods also enable the development of scalable custom AI models for specific pathology endpoints, companion diagnostics and predictive models integrating multi-omic data.
"Reveal's exceptional AI and machine learning capabilities will support more objective tissue biomarker quantitation and will enable a broader and faster deployment of our histological services," said Martin LeBlanc, CEO of CellCarta. "Acquiring this leading business is part of a game-changing strategy to expand our services to better support our global clients who are actively seeking more objective, reproducible and scalable methods for tissue biomarker assessment, deployed within a robust quality and regulatory platform."
"We are excited to join forces with CellCarta," said Claire Weston, PhD, CEO and Co-Founder of Reveal. "Reveal's broad portfolio of automated digital assays target Oncology, NASH, Neuroscience, Fibrosis, Inflammation and other therapeutic areas. We see great opportunity in combining these AI capabilities with CellCarta driving towards better diagnoses and more meaningful clinical trials on a global scale."
About CellCarta
CellCarta is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as related specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials. The company operates globally with 10 facilities located in Canada, USA, Belgium, Australia, and China.
For more information: cellcarta.com
About Reveal Biosciences
Reveal Biosciences has created a new generation of Pathology Intelligence(TM) to enhance research and improve patient outcomes globally. Reveal's imageDx(TM) pathology platform provides AI data analytics and cloud-based whole slide image management to Life Sciences and Healthcare. With a world class team of data and research scientists focused on addressing some of the biggest problems in healthcare, Reveal has developed a pipeline of AI-based digital assays for preclinical research, clinical trials, and diagnostics.
For more information: revealbio.com
Media Contact for CellCarta: Prosek Partners, Brian Schaffer / Kristen Duarte, [email protected] / [email protected]; Marketing & Communications: Guylaine Galipeau, Global Marketing Director, CellCarta, [email protected]
Logo - https://mma.prnewswire.com/media/1507305/CellCarta_CellCarta_Strengthens_its_Histological_Biomarker_Franc.jpg
Logo - https://mma.prnewswire.com/media/1507125/CellCarta_CellCarta_Strengthens_its_Histological_Biomarker_Franc.jpg
ข่าวReveal Biosciences+the acquisitionวันนี้
Pavena Foundation for Children & Women Receives Vehicle Donation from the International Women's Club of Thailand
Pavena Hongsakula (6th from right), President of the Pavena Foundation for Children and Women, recently presided over a special ceremony celebrating the acquisition of a new vehicle for the Foundation. This meaningful addition was made possible through a generous donation of 500,000 baht from the International Women's Club of Thailand (IWC), led by its President, Diana Foo (7th from right). The donation was the result of successful fundraising initiatives organized by the IWC, with the valued
NIPPON EXPRESS HOLDINGS Completes Procedure to Make Germany's SH HoldCo Wholly-owned Subsidiary
NIPPON EXPRESS HOLDINGS, INC. - Completion of Acquisition (Subsidiarization) of SH HoldCo GmbH Shares - NIPPON EXPRESS HOLDINGS, INC. is pleased to announce that the agreement concluded on September 30,...
Betagro Expands Its Footprint in Singapore with THB 1.9 Billion Acquisition of Eggriculture to Drive Sustainable Growth
—
Betagro Public Company Limited (...
CHARTERED GROUP ACQUIRED SHAREHOLDING IN MFC, THE MINISTRY OF FINANCE AND GOVERNMENT SAVINGS BANK RETAINED HOLDINGS, REINFORCING SUPPORT FOR MFC'S WORLD-CLASS ASPIRATIONS
Energos Infrastructure Announces Transformative Marine LNG Asset Transaction with Long Term Charter Contracts in Germany
Energos Infrastructure ("Energos" or the "Company"), an international marine LNG infrastructure company, majority-controlled by Apollo-managed funds (NYSE: APO) and minority...
SCGP Completed the Acquisition of 70% Stake in Starprint Vietnam JSC, Advancing the Footprint in Premium Offset Folding Carton Packaging in ASEAN
—
SCGP has ac...
EGCO Group Acquires 30% Interest in Infrastructure and Utility Business in Indonesia
—
Electricity Generating Public Company Limited or EGCO Group has str...